The Multidisciplinary Assessment and Management of CVD Risk in HIV Infection
Sponsored by The Academy for Continued Healthcare Learning (ACHL).
This activity is supported by an educational grant from Gilead Sciences, Inc.
Scroll to the Bottom of this Information to Begin this Course
Release date: October 9, 2017
Valid through: October 9, 2018
Specialty: Cardiology, Infectious Disease, Epidemiology, Internal Medicine, Primary Care, Family/General Practice
Topic: HIV Infection
Estimated Time to Complete Activity: 30 minutes
This activity is designed for cardiologists, infectious disease specialists, primary care physicians, and other clinicians interested in the management of patients with HIV-related cardiovascular disease.
HIV-infected individuals have an increased risk of CVD. Research has identified characteristics of HIV infection itself that influence CVD risks, yet their precise roles and potential as therapeutic targets are unclear. Initiation of ART and management of traditional CVD risk factors are paramount to reducing risk, but additional strategies are needed.
Upon completion of this activity, participants will be able to:
- Discuss CVD risks in HIV-patients and the importance of early initiation of ART
- Apply available CVD risk screening tools to HIV-positive patients
- Outline the role of the multidisciplinary care team in the assessment and management of CVD risks in HIV-infected patients
- Physicians — maximum of 0.5 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Priscilla Hsue, MD, FACC
Professor of Medicine
University of California, San Francisco
Director, HIV Cardiology Clinic
San Francisco General Hospital
San Francisco, CA
E. Turner Overton, MD
Associate Professor of Medicine
Division of Infectious Diseases
Medical Director, UAB 1917 HIV Clinic
University of Alabama at Birmingham
Physician Continuing Medical Education
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
The following financial relationships have been provided:
- Grants/Research Support: Pfizer.
- Honoraria Recipient: Gilead Sciences.
- Consultant: Merck & Company
- Research Support: Gilead Sciences and ViiV Healthcare
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
Instructions for Participation and Credit
This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pre-test, view the online activity, and complete the post-test and evaluation. To receive credit, 66% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions about this activity, please contact Katlyn Cooper at email@example.com.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.
Disclosure of Unlabeled Use
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.